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VABSTRACT
Measures of muscle mass and fat mass in the 
identification of metabolic abnormalities in older Korean 
adults
Ji Hye Park
Department of Public Health
The graduate School of Yonsei University
(Directed by Professor Hyeon Chang Kim)
OBJECTIVES: 
We investigated the association of the sex-associated changes of muscle mass 
and fat mass with metabolic abnormalities in an older Korean population.
VI
METHODS: 
We conducted a cross-sectional analysis of the baseline data from the cohort 
study conducted in the Korean Urban Rural Elderly (KURE) study, which is a 
population-based longitudinal study of health determinants among elderly persons 
aged 65 years or older (381 men, 747 women). Metabolic syndrome was defined 
according to the National Cholesterol Education Program’s ATP-III criteria (≥3 of 
the following abnormalities): waist circumference greater than 90 cm in men and 
80 cm in women; serum triglycerides level of at least 150 mg/dL; high-density 
lipoprotein (HDL) cholesterol level of less than 40 mg/dL in men and 50 mg/dL in 
women; blood pressure of at least 130/85 mmHg; or serum glucose level of at 
least 100 mg/dL. The association between muscle and fat mass and metabolic 
syndrome was assessed by serial logistic regression models.
RESULTS: 
Fat mass was significantly associated with all components of the metabolic 
syndrome in both sexes. After adjustment for potential confounders including fat 
mass, muscle mass was associated with high blood pressure (ASM/Ht2; OR= 2.46, 
95% CI = 1.61-3.75), low HDL cholesterol (ASM; OR= 1.91, 95% CI = 1.17-2.88
and ASM/Ht2; OR= 2.25, 95% CI = 1.49-3.38), high glucose (ASM; OR= 1.61, 95% 
CI = 1.05-2.48) and metabolic syndrome (ASM/Ht2; OR= 1.65, 95% CI = 1.12-
VII
2.42) for women and low HDL cholesterol (ASM/Ht2; OR= 1.88, 95% CI = 1.01-
3.49) for men.
CONCLUSIONS: 
In older persons, fat mass was associated with all of the metabolic syndrome
components. In contrast, muscle mass was associated with all of the metabolic 
syndrome components in women, but not in men. More studies are needed to 
explain the sex difference of the associations.
Keywords: Muscle mass, fat mass, metabolic abnormality, elderly
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I. INTRODUCTION
1. Background
Metabolic syndrome is defined as a cluster of hypertension, hyperglycemia, 
dyslipidemia, and abdominal obesity ("Third Report of the National Cholesterol 
2Education Program (NCEP) Expert Panel on Detection, Evaluation, and 
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final 
report" 2002). Metabolic syndrome is associated with cardiovascular disease 
which is the leading cause of mortality and morbidity . In Korea, the prevalence of 
metabolic syndrome, according to the National Cholesterol Education Program 
(NCEP)–Adult Treatment Panel (ATP) III, was 25.7 % in men and 31.9 % in 
women (Yoon et al. 2007) and the prevalence of metabolic syndrome were
steadily increasing in elderly people (Ford, Giles and Dietz 2002; Park et al. 2007).
In addition, previous studies have suggested that the effects of metabolic 
syndrome may depend on age (Roriz-Cruz et al. 2007). Insulin resistance, one of 
the components of metabolic syndrome, has been considered as a contributing 
factor to age-related muscle mass loss, which is causally related to decline in 
functional ability. Moreover, older individuals tend to have a greater proportion of 
fat than younger people with the same BMI. Both cross-sectional and longitudinal 
studies have shown that age-related body composition changes, such as fat mass 
increase and muscle mass decrease (Baumgartner et al. 1995; Forbes 1999). The 
abdominal obesity including fat mass was well known to be strongly associated 
with metabolic syndrome (Bosy-Westphal et al. 2006b) and lower muscle mass,
termed sarcopenia, was also associated with metabolic syndrome (Ishii et al. 
2014).
32. Objective
There is no unanimous view about the standard criteria of sarcopenia to apply 
to define low muscle mass, since classification of sarcopenia differs by ethnic 
groups and equipment for measuring the muscle mass (Alexandre Tda et al. 2014).
Therefore, we assessed the association between absolute muscle mass and 
metabolic syndrome components without classifying sarcopenia among older 
Korean adults. We also investigated the association of the sex-associated changes 
of muscle mass and fat mass with metabolic abnormalities.
4II. METHODS
1. Study population
The study is conducted using baseline data collected from Korean elderly 
participating in the Korean Urban Rural Elderly (KURE) study (Lee et al. 2014). 
The KURE study is a community-based prospective cohort study on health, aging, 
and common geriatric disorders of Korean elderly persons aged at least 65 years. 
To construct a cohort reflecting both urban and rural areas, we selected two
representative communities in the country. 
Between July and December 2014, a bioelectrical impedance ancillary study 
was performed for 1285 permanent residents. After excluding 175 participants 
with past history of cancer or stroke, 1128 participants were eligible for the 
current cross-sectional analysis (Figure 1). Among them, 760 participants were 
measured for anthropometric parameters and examined for fasting blood test in 
2014, and 368 participants were measured for anthropometric parameters in 2014 
and examined for fasting blood test in 2012. All participants provided written 
informed consents, and the study protocol was approved by the Institutional 
Review Board of Severance Hospital, Yonsei University College of Medicine.
5Figure1. Flowchart of the selection criteria for the final study population
1285 patients analyzed
Participated n = 1128
381 men and 747 women
157 patients excluded 
(Stroke, cancer)
62. Measurements
1) Questionnaire 
Participants were individually interviewed using standardized questionnaires 
to obtain information about their general characteristics, medical history, 
medication use, and lifestyle behaviors. Trained interviewers carried out the 
questionnaire surveys according to the predefined protocol, and double-checked 
whether responses were inappropriate or missing. Smoking status was classified 
as current smokers or nonsmokers (past smokers or those who had never smoked). 
Alcohol consumption was categorized as regular alcohol drinking or other 
(participants who drink less than once a week or not at all). Physical activity was 
categorized as regular exercise or no exercise.
2) Physical Examination
We measured height and weight with subjects in light clothing and calculated 
body mass index (BMI) as weight in kilograms divided by the square of height in 
meters (kg/m2). Waist circumference was measured between the lower borders of 
the rib cage and the iliac crest with a measuring tape (SECA-201; SECA, 
Hamburg, Germany). Resting blood pressure was measured twice by an automatic 
sphygmomanometer (Dinamap 1846 SX/P; GE Healthcare, Waukesha, WI, USA) 
7with the participant in the sitting position at least 5 minute intervals. If the 
difference between the first and second measurement was more than 10 mmHg for 
either systolic or diastolic blood pressure, a third measurement was performed, 
and the last two measurements were averaged for analyses. Muscle mass and fat 
mass were measured by bioelectrical impedance analysis (BIA) using an Inbody 
720 machine (Biospace, Seoul, Korea). Appendicular skeletal muscle mass (ASM) 
was derived as the sum of the muscle mass of the four limbs (Cruz-Jentoft et al. 
2010). We used ASM divided by weight (ASM/Wt) and by height squared 
(ASM/Ht2) as muscle mass indices; fat mass divided by weight (Body fat/Wt) and 
by height squared (Body fat/Ht2) as fat mass indices. The results of our study did 
not differ significantly when divided by weight and by height squared. Therefore, 
only ASM/Ht2 and Body fat/Ht2 indices were used in the analysis. Grip strength 
was measured with a hand dynamometer with participants seated, their elbow by 
their side and flexed to right angles, and a neutral wrist position. The 
measurements were conducted in each hand with 20 seconds rest intervals, and 
the mean value of four measures was used in the analysis.
3) Laboratory Assays
Blood samples were collected from the antecubital vein after at least an 8 hour 
fast. Enzymatic methods were applied to measure total cholesterol, HDL 
8cholesterol, and triglycerides and fasting blood glucose level were measured by 
colorimetry method with Auto Analyzer (ADVIA 1800; Siemens Healthcare 
Diagnostics Inc., Deerfield, IL, USA). Low-density lipoprotein cholesterol was 
calculated using the Friedewald’ method (Friedewald, Levy and Fredrickson 
1972).
3. Definition of metabolic abnormalities
Metabolic syndrome was defined based on the National Cholesterol Education 
Program Adult Treatment Panel III (NCEP-ATP III) criteria (Alberti et al. 2009). 
The presence of any three of the following five abnormalities constitutes a 
diagnosis of metabolic syndrome: (i) waist circumference >90 cm in men and >80 
cm in women; (ii) elevated triglycerides with fasting plasma triglycerides ≥150 
mg/dL; (iii) low HDL cholesterol with fasting HDL cholesterol <40 mg/dL in men 
and <50 mg/dL in women; (iv) elevated blood pressure with systolic blood 
pressure ≥130 mmHg and/or diastolic blood pressure ≥85 mmHg; (v) elevated 
fasting plasma glucose with fasting plasma glucose ≥100 mg/dL.
94. Statistical Analysis
Differences in subject characteristics between men and women were examined 
using Student’s t-test, ANOVA or Wilcoxon rank-sum test (for continuous 
variables) and chi-square test (for categorical variables). The correlation between 
muscle mass and fat mass and other variables were evaluated by the Pearson’s 
correlation coefficient controlling for age, smoking status, physical activity, and 
alcohol intake. Also, the Spearman’s correlation coefficients were used for skewed 
variables. We employed logistic regression analysis to evaluate the association 
between muscles mass and fat mass. Multiple logistic regression analysis was 
used to assess the odds ratio for the individual metabolic abnormalities per one 
unit increase in the muscle mass and fat mass. We applied the following serial 
models: age-adjusted (model 1); age, potential confounders such as smoking, 
drinking and physical activity-adjusted (model 2). In the final model, age, 
potential confounders and fat mass or muscle mass (ASM with corresponding 
body fat and ASM/Ht2 with corresponding body fat/Ht2) were included (model 3). 
Furthermore, the receiver operating characteristic (ROC) analysis was used to 
compare the discriminative power of muscle mass and fat mass. All statistical 
analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC, USA), 
and statistical significance was defined as a two-sided p-value less than ≤ 0.05.
10
III. RESULTS
1. Characteristics of study populations
General characteristics for men and women participants are shown in Table 1. 
The variables were significantly different between men and women, with the 
exception of triglycerides and insulin. Men had higher muscle mass, blood 
pressure and fasting glucose, tended to smoke more, and drank more alcohol than 
women. Women had higher fat mass, total cholesterol, HDL cholesterol and LDL
cholesterol, and more physical activity than men/higher physical activity level 
than men.
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Table 1. Characteristics of study populations
Variables Men (n=381) Women (n=747) p-value
Age, year 72.5 ± 4.2 71.1 ± 4.4 <.001
Height, cm 164.9 ± 5.7 152.7 ± 5.3 <.001
Weight, kg 65.0 ± 8.4 57.1 ± 7.9 <.001
Body mass index, kg/m2 23.9 ± 2.7 24.5 ± 3.1 0.001
Waist circumference, cm 86.0 ± 8.7 82.6 ± 8.9 <.001
ASM, kg 20.5 ± 2.7 14.5 ± 2.0 <.001
Body fat, kg 16.4 ± 5.3 20.1 ± 5.8 <.001
ASM/Ht² 7.5 ± 0.7 6.2 ± 0.6 <.001
Body fat/Ht² 6.0 ± 2.0 8.6 ± 2.5 <.001
Grip strength, kg 32.0 ± 5.8 19.9 ± 4.4 <.001
Lifestyle characteristics
Current smoker, % 265 (69.7) 12 (1.6) <.001
Drinker, % 268 (70.3) 180 (24.1) <.001
Physical inactivity, % 129 (33.9) 296 (39.6) <.001
Metabolic risk factors
Systolic blood pressure, mmHg 128.9 ± 13.6 127.0 ± 15.8 0.040
Diastolic blood pressure, mmHg 74.7 ± 8.5 73.4 ± 8.6 0.012
Total cholesterol, mg/dL 172.5 ± 33.1 184.9 ± 34.4 <.001
HDL cholesterol, mg/dL 47.4 ± 11.6 51.1 ± 12.2 <.001
LDL cholesterol, mg/dL 100.3 ± 28.9 108.7 ± 29.8 <.001
Triglycerides, mg/dL 109 [83-150] 112 [83-153] 0.767
Fasting glucose, mg/dL 98 [91-108] 94 [88-104] 0.027
Insulin, uIU/L 5.1 [3.3-8.1] 6.1 [4.1-9.5] 0.124
Data are expressed as means ± standard deviation, median [inter quartile range] and number (%)
Abbreviations: ASM, appendicular skeletal muscle; HDL, high density lipoprotein; 
LDL, low density lipoprotein
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2. Description of study populations by tertiles of muscle mass and body fat 
Description of men and women by tertile of ASM and body fat are shown in 
Table 2 and 3. Men and women in the lowest tertile of ASM were older and 
shorter, had a lower weight, BMI, waist circumference and body fat, and had a 
lower grip strength compared with those in the highest tertile (Table 2). Among
the highest tertile of ASM, low HDL cholesterol, high glucose and metabolic 
syndrome were significantly more prevalent in women (p = 0.02, p = 0.01, and p
<.001, respectively), while metabolic syndrome was significantly more prevalent 
in men (p = 0.004). Men and women in the highest tertile of body fat had a higher 
weight, BMI and waist circumference compared with those in the lowest tertile. 
Among the highest tertile of body fat, metabolic syndrome and its components
were significantly more prevalent in both sexes (Table 3).
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Table 2. Description of men and women by tertiles of muscle mass
Variables
Men Women
  Tertile 1   Tertile 2   Tertile 3 p-value     Tertile 1    Tertile 2    Tertile 3 p-value
Age, year 74.3 ± 4.0 72.1 ± 4.1 71.1 ± 3.8 <.001 72.6 ± 4.8 71.1 ± 4.1 69.6 ± 3.7 <.001
Height, cm 160.3 ± 4.5 164.8 ± 3.7 169.5 ± 4.7 <.001 148.4 ± 4.0 152.7 ± 4.0 156.9 ± 4.1 <.001
Weight, kg 58.3 ± 6.8 64.3 ± 4.9 72.3 ± 6.6 <.001 50.9 ± 5.6 56.7 ± 5.4 63.6 ± 6.9 <.001
Body mass index, kg/m2 22.7 ± 2.8 23.7 ± 2.4 25.2 ± 2.4 <.001 23.2 ± 2.9 24.4 ± 2.9 25.9 ± 3.0 <.001
Waist circumference, cm 82.1 ± 8.7 85.4 ± 7.9 90.4 ± 7.4 <.001 79.1 ± 8.4 82.1 ± 8.4 86.7 ± 8.2 <.001
ASM, kg 17.8 ± 1.5 20.4 ± 0.6 23.4 ± 1.8 <.001 17.7 ± 5.2 20.0 ± 5.3 22.6 ± 5.9 <.001
ASM/Ht² 6.9 ± 0.6 7.5 ± 0.4 8.2 ± 0.6 <.001 8.1 ± 2.5 8.6 ± 2.5 9.2 ± 2.5 <.001
Body fat, kg 15.0 ± 5.7 15.9 ± 4.4 18.2 ± 5.2 <.001 12.3 ± 1.0 14.4 ± 0.5 16.7 ± 1.1 <.001
Body fat/Ht² 5.9 ± 2.2 5.9 ± 1.7 6.4 ± 1.9 0.082 5.6 ± 0.4 6.2 ± 0.3 6.8 ± 0.4 <.001
Grip strength, kg 29.5 ± 4.6 31.8 ± 5.6 34.7 ± 5.9 <.001 18.1 ± 3.9 19.3 ± 4.0 22.2 ± 4.3 <.001
Metabolic abnormality
High blood pressure 66 (53.2) 75 (58.6) 78 (61.4) 0.411 123 (49.6) 129 (51.6) 146 (59.4) 0.072
Low HDL cholesterol 28 (22.4) 44 (34.4) 48 (37.8) 0.022 116 (46.8) 142 (56.8) 144 (58.5) 0.018
High triglycerides 24 (19.2) 33 (25.8) 39 (30.7) 0.108 58 (23.4) 65 (26.0) 69 (28.1) 0.494
High glucose 50 (40.0) 56 (43.8) 60 (47.2) 0.511 67 (27.2) 88 (35.2) 98 (39.8) 0.010
Metabolic syndrome 33 (26.4) 47 (36.7) 59 (46.5) 0.004 88 (35.5) 111 (44.4) 136 (55.3) <.001
Data are expressed as means ± standard deviation, median [inter quartile range] and number (%)
Abbreviations: ASM, appendicular skeletal muscle; HDL, high density lipoprotein
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Table 3. Description of men and women by tertiles of body fat
Variables
Men Women
   Tertile 1    Tertile 2    Tertile 3 p-value    Tertile 1     Tertile 2    Tertile 3 p-value
Age, year 72.7 ± 4.4 72.4 ± 3.8 72.4 ± 4.3 0.742 71.0 ± 4.2 71.3 ± 4.9 71.0 ± 4.0 0.549
Height, cm 164.9 ± 5.5 164.4 ± 6.0 165.4 ± 5.7 0.365 152.1 ± 5.3 152.6 ± 5.1 153.3 ± 5.6 0.062
Weight, kg 57.6 ± 6.1 64.9 ± 5.0 72.2 ± 6.5 <.001 49.6 ± 4.5 56.7 ± 4.2 64.7 ± 6.0 <.001
Body mass index, kg/ m2 21.2 ± 2.0 24.0 ± 1.4 26.4 ± 1.7 <.001 21.4 ± 1.8 24.4 ± 1.5 27.6 ± 2.2 <.001
Waist circumference, cm 78.1 ± 7.7 86.2 ± 4.8 93.3 ± 5.3 <.001 74.6 ± 6.3 83.1 ± 5.2 90.0 ± 7.1 <.001
Body fat, kg 10.7 ± 2.2 16.0 ± 1.3 22.2 ± 3.0 <.001 14.0 ± 2.7 19.8 ± 1.4 26.4 ± 3.7 <.001
Body fat/Ht² 3.9 ± 0.9 5.9 ± 0.6 8.1 ± 1.2 <.001 6.1 ± 1.3 8.5 ± 0.8 11.3 ± 1.7 <.001
ASM, kg 19.7 ± 2.6 20.5 ± 2.3 21.3 ± 2.9 <.001 13.6 ± 1.7 14.4 ± 1.8 15.4 ± 2.0 <.001
ASM/Ht² 7.2 ± 0.8 7.6 ± 0.5 7.8 ± 0.7 <.001 5.9 ± 0.5 6.2 ± 0.5 6.5 ± 0.6 <.001
Grip strength, kg 31.6 ± 5.7 32.2 ± 5.1 32.2 ± 6.5 0.659 20.0 ± 4.0 19.7 ± 4.7 19.9 ± 4.4 0.808
Metabolic abnormality
High blood pressure 50 (40.0) 68 (55.3) 101 (77.1) <.001 94 (38.2) 128 (52.0) 176 (69.9) <.001
Low HDL cholesterol 23 (18.4) 43 (34.7) 54 (41.2) <.001 109 (44.3) 147 (59.8) 146 (57.9) 0.001
High triglycerides 17 (13.6) 37 (29.8) 42 (32.1) <.001 47 (19.1) 73 (39.7) 72 (28.6) 0.013
High glucose 38 (30.4) 49 (39.5) 79 (60.3) <.001 61 (24.8) 88 (35.8) 104 (41.3) <.001
Metabolic syndrome 13 (10.4) 37 (29.8) 89 (67.9) <.001 52 (21.1) 121 (49.2) 162 (64.3) <.001
Data are expressed as means ± standard deviation, median [inter quartile range] and number (%)
Abbreviations: ASM, appendicular skeletal muscle; HDL, high density lipoprotein
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3. Correlations between muscle mass and fat mass with metabolic variables
The associations between muscle mass and fat mass with metabolic variables after 
adjusting for age, smoking, drinking and physical activity are shown in Table 4 and 5. For 
man, ASM was significantly positively correlated with body fat (r = 0.237, p < .001), insulin
(r = 0.147, p = 0.004) and grip strength (r = 0.271, p < .001), was significantly negatively 
correlated with total cholesterol (r = -0.112, p = 0.030) and HDL cholesterol (r = -0.187, p
< .001); ASM/Ht2 was significantly positively correlated with body fat (r = 0.269, p < .001), 
body fat/Ht2 (r = 0.216, p < .001), blood pressure (r = 0.104, p = 0.045), insulin (r = 0.220, p 
< .001) and grip strength (r = 0.199, p < .001), was significantly negatively correlated with
HDL cholesterol (r = -0.210, p < .001). Body fat and body fat/Ht2 was significantly positively 
correlated with ASM/Ht2, HDL cholesterol, blood pressure, triglycerides, fasting glucose and
insulin, was significantly negatively correlated with HDL cholesterol (Table 4). For women, 
association muscle mass and fat mass was stronger than in men (r = 0.237, p < .001 for men 
and r = 0.417, p < .001 for women). Both muscle mass and fat mass indices were
significantly positively correlated with blood pressure (ASM excepted), triglycerides, fasting 
glucose and insulin, were significantly negatively correlated with HDL cholesterol (Table 5). 
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Table 4. Correlation analysis between muscle mass and fat mass with metabolic variables in men
Variables
ASM Body fat ASM/Ht² Body fat/Ht²
r p-value r p-value r p-value r p-value
Height, cm 0.696 <.001 0.060 0.246 0.196 <.001 -0.153 0.003
Weight, kg 0.759 <.001 0.785 <.001 0.697 <.001 0.677 <.001
Body mass index, kg/m2 0.414 <.001 0.832 <.001 0.653 <.001 0.846 <.001
Waist circumference, cm 0.459 <.001 0.785 <.001 0.507 <.001 0.738 <.001
ASM, kg - - 0.237 <.001 0.837 <.001 0.079 0.127
Body fat, kg 0.237 <.001 - - 0.269 <.001 0.975 <.001
ASM/Ht² 0.837 <.001 0.269 <.001 - - 0.216 <.001
Body fat/Ht² 0.079 0.127 0.975 <.001 0.216 <.001 - -
Grip strength, kg 0.271 <.001 -0.001 0.988 0.199 <.001 -0.047 0.363
Blood pressure, mmHg 0.053 0.308 0.150 0.004 0.104 0.045 0.159 0.002 
Total cholesterol, mg/dL -0.112 0.030 -0.033 0.529 -0.085 0.102 -0.016 0.753 
HDL cholesterol, mg/dL -0.187 <.001 -0.321 <.001 -0.210 <.001 -0.311 <.001
Triglycerides, mg/dL* 0.068 0.186 0.337 <.001 0.079 0.126 0.325 <.001
Fasting glucose, mg/dL* 0.021 0.690 0.240 <.001 0.035 0.498 0.236 <.001
Insulin, uIU/L* 0.147 0.004 0.644 <.001 0.220 <.001 0.631 <.001
Adjustment for age, smoking status, physical activity, and alcohol intake
Abbreviations: ASM, Appendicular skeletal muscle mass; HDL, high density lipoprotein
Correlation coefficients (r) and p-values were calculated with Pearson's (for normally distributed variables) or 
*Spearman's (for non-normally distributed variables) correlation coefficients.
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Table 5. Correlation between muscle mass and fat mass with metabolic variables in women
Variables
ASM Body fat ASM/Ht² Body fat/Ht²
r p-value r p-value r p-value r p-value
Height, cm 0.717 <.001 0.081 0.027 0.279 <.001 -0.154 <.001
Weight, kg 0.739 <.001 0.889 <.001 0.747 <.001 0.789 <.001
Body mass index, kg/m2 0.411 <.001 0.908 <.001 0.651 <.001 0.930 <.001
Waist circumference, cm 0.433 <.001 0.798 <.001 0.538 <.001 0.773 <.001
ASM, kg - - 0.417 <.001 0.867 <.001 0.242 <.001
Body fat, kg 0.417 <.001 - - 0.512 <.001 0.969 <.001
ASM/Ht² 0.867 <.001 0.512 <.001 - - 0.439 <.001
Body fat/Ht² 0.242 <.001 0.969 <.001 0.439 <.001 - -
Grip strength, kg 0.359 <.001 -0.002 0.964 0.273 <.001 -0.077 0.037
Blood pressure, mmHg 0.035 0.347 0.112 0.002 0.102 0.005 0.126 0.001 
Total cholesterol, mg/dL -0.070 0.057 -0.044 0.232 -0.079 0.032 -0.040 0.273 
HDL cholesterol, mg/dL -0.218 <.001 -0.175 <.001 -0.250 <.001 -0.156 <.001
Triglycerides, mg/dL* 0.107 0.004 0.197 <.001 0.140 <.001 0.183 <.001
Fasting glucose, mg/dL* 0.172 <.001 0.169 <.001 0.142 <.001 0.135 <.001
Insulin, uIU/L* 0.252 <.001 0.440 <.001 0.290 <.001 0.413 <.001
Adjustment for age, smoking status, physical activity, and alcohol intake
Abbreviations: ASM, Appendicular skeletal muscle mass; HDL, high density lipoprotein
Correlation coefficients (r) and p-values were calculated with Pearson's (for normally distributed variables) or 
*Spearman's (for non-normally distributed variables) correlation coefficients.
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4. Correlations between muscle mass and fat mass
The relationships between muscle mass and fat mass were also presented using scatter 
plots, separately for men and women (Figure 2). In men, ASM was significantly and 
positively correlation with body fat (r = 0.237, p < .001), and ASM/Ht2 was significantly and 
positively correlation with body fat/Ht² (r = 0.216, p < .001). In women, ASM was 
significantly and positively correlation with body fat (r = 0.417, p < .001), and ASM/Ht2 was 
significantly and positively correlation with body fat/Ht² (r= 0.512, p <.001). These results 
provided evidence that muscle mass is strongly correlated with fat mass in women than in 
men.
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Figure.2 The relationship between muscle mass and fat mass in men and women
Men Men
r = .237, p < .001
r = .512, p < .001
r = .216, p < .001
r = .417, p < .001
Women (n=747)
r = 0.512, p <.001
Women (n=747)
r = 0.417, p <.001
Men (n=381)
r = 0.237, p <.001
Men (n=381)
r = 0.216, p <.001
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5. Association between muscle mass and fat mass and metabolic abnormalities
Table 6, 7, 8 and 9 shows association between tertile of muscle mass and fat mass and 
metabolic abnormalities using multiple logistic regression analysis in each sex. In men, body 
fat and body fat/Ht² were associated with all of the metabolic abnormalities, and further 
adjustment for muscle mass and potential confounders were significantly associated with all 
of the metabolic abnormalities. The highest tertile of body fat and body fat/Ht² were 17.29
and 16.43 times, respectively, more likely to have an increased risk of metabolic syndrome
than those in lowest tertile. In contrast, ASM and ASM/Ht2 were associated with low HDL 
cholesterol and metabolic syndrome, but after adjustment for body fat and potential 
confounders the association was significant with low HDL cholesterol (ASM; OR = 2.24, 95% 
CI = 1.48-3.38) (Table 6 and 7). In women, body fat and body fat/Ht² were associated with all 
of the metabolic abnormalities, but further adjustment for muscle mass and potential 
confounders was significantly associated with high blood pressure, high glucose and 
metabolic syndrome. The highest tertile of body fat and body fat/Ht² were 5.14 and 4.15
times, respectively, more likely to have an increased risk of metabolic syndrome than those in 
lowest tertile. In contrast, ASM was associated with high blood pressure, low HDL 
cholesterol, high glucose and metabolic syndrome, and further adjustment for body fat mass 
and potential confounders was significantly associated with low HDL cholesterol (OR = 1.90, 
95% CI 1.26-2.27), high glucose (OR = 1.59, 95% CI = 1.03-2.45) and metabolic syndrome
(OR = 1.99, 95% CI = 1.28-3.09) (Table 8). ASM/Ht2 was associated with all of the 
metabolic abnormalities, but further adjustment for body fat/Ht2 and potential confounders 
was significantly associated with high blood pressure (OR = 2.39, 95% CI = 1.56-3.66), low 
HDL cholesterol (OR = 2.24, 95% CI = 1.48-3.38) and metabolic syndrome (OR = 2.47, 95% 
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CI = 1.60-3.81) (Table 9).
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Abbreviations: ASM, appendicular skeletal muscle; HDL, high density lipoprotein
The lowest tertile (tertile1) was used as reference group.
Model1: adjusted for age.
Model2: adjusted for age, smoking, drinking and physical activity.
Model3: adjusted for age, smoking, drinking, physical activity, and body fat (ASM).
Table 6. Logistic regression models of ASM and body fat mass for metabolic 
abnormality in men
Men (n=381)
ASM Body fat
Tertile 2 Tertile 3 Tertile 2 Tertile 3
OR (95% CI) OR (95% CI)
High blood pressure
Model 1 1.40 (0.83, 2.34) 1.66 (0.97, 2.83) 1.90 (1.14, 3.15) 5.21 (3.01, 9.00) 
Model 2 1.42 (0.84, 2.39) 1.57 (0.91, 2.71) 1.96 (1.17, 3.30) 5.43 (3.10, 9.48) 
Model 3 1.24 (0.72, 2.15) 1.02 (0.56, 1.86) 1.96 (1.16, 3.30) 5.43 (3.06, 9.64)
Low HDL cholesterol
Model 1 1.83 (1.04, 3.24) 2.13 (1.20, 3.81) 2.34 (1.31, 4.21) 3.10 (1.75, 5.48) 
Model 2 1.85 (1.04, 3.31) 2.44 (1.33, 4.45) 2.42 (1.33, 4.40) 3.29 (1.83, 5.90)
Model 3 1.72 (0.95, 3.09) 1.88 (1.01, 3.49) 2.26 (1.23, 4.12) 2.81 (1.54, 5.12) 
High triglycerides
Model 1 1.30 (0.71, 3.40) 1.58 (0.86, 2.92) 2.68 (1.41, 5.11) 2.97 (1.58, 5.60) 
Model 2 1.27 (0.69, 2.35) 1.66 (0.89, 3.10) 2.83 (1.47, 5.45) 3.12 (1.64, 5.93) 
Model 3 1.24 (0.67, 2.31) 1.35 (0.71, 2.56) 2.81 (1.46, 5.41) 3.06 (1.59, 5.89) 
High glucose
Model 1 1.14 (0.68, 1.90) 1.29 (0.76, 2.18) 1.49 (0.88, 2.51) 3.46 (2.06, 5.81)
Model 2 1.13 (0.67, 1.88) 1.27 (0.75, 2.17) 1.46 (0.86, 2.48) 3.44 (3.04, 5.79) 
Model 3 1.04 (0.61, 1.76) 0.93 (0.53, 1.64) 1.46 (0.86, 2.49) 3.44 (2.01, 5.88) 
Metabolic syndrome
Model 1 1.69 (0.97, 2.92) 2.57 (1.47, 4.50) 3.66 (1.83, 7.31) 18.24 (9.23, 36.07)
Model 2 1.66 (0.96, 2.89) 2.68 (1.52, 4.73) 3.75 (1.87, 7.54) 19.10 (9.57, 38.12) 
Model 3 1.59 (0.85, 2.98) 1.54 (0.80, 2.99) 3.57 (1.77, 7.19) 17.29 (8.60, 34.75) 
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Table 7. Logistic regression models of ASM/Ht² and Body fat/Ht² for metabolic 
abnormality in men
Men (n=381)
ASM/Ht² Body fat/Ht²
Tertile 2 Tertile 3 Tertile 2 Tertile 3
OR (95% CI) OR (95% CI)
High blood pressure
Model 1 1.65 (0.99, 2.76)  1.74 (1.03, 2.94)  1.64 (1.00, 2.71)  5.70 (3.25, 10.00)  
Model 2 1.58 (0.94, 2.68) 1.68 (0.98, 2.88) 1.68 (1.00, 2.82) 6.06 (3.41, 10.78) 
Model 3 1.21 (0.69, 2.11) 1.02 (0.56, 1.85) 1.68 (0.99, 2.85) 6.06 (3.34, 11.01) 
Low HDL cholesterol
Model 1 1.45 (0.83, 2.54) 1.79 (1.02, 3.13) 3.06 (1.70, 5.52)  3.22 (1.79, 5.81)  
Model 2 1.62 (0.91, 2.88) 1.99 (1.11, 3.58) 3.29 (1.79, 6.05) 3.38 (1.85, 6.17) 
Model 3 1.41 (0.78, 2.53) 1.52 (0.83, 2.80) 3.00 (1.62, 5.55) 2.85 (1.53, 5.31) 
High triglycerides
Model 1 1.74 (0.95, 3.16) 1.41 (0.76, 2.62) 2.61 (1.39, 4.89)  2.68 (1.43, 5.03)  
Model 2 1.89 (1.02, 3.48) 1.53 (0.81, 2.89) 2.70 (1.42, 5.12) 2.81 (1.48, 5.33) 
Model 3 1.66 (0.89, 3.09) 1.20 (0.62, 2.31) 2.67 (1.39, 5.11) 2.76 (1.43, 5.36) 
High glucose
Model 1 1.79 (1.07, 2.99) 1.54 (0.91, 2.61) 1.78 (1.06, 3.00)  3.33 (1.98, 5.61)  
Model 2 1.86 (1.10, 3.13) 1.57 (0.92, 2.68) 1.71 (1.01, 2.90) 3.28 (1.94, 5.56) 
Model 3 1.57 (0.92, 2.70) 1.13 (0.64, 2.00) 1.72 (1.01, 2.95) 3.32 (1.92, 5.75) 
Metabolic syndrome
Model 1 1.98 (1.15, 3.43) 2.71 (1.55, 4.73) 3.91 (1.97, 7.75)  18.12 (9.14, 35.92)  
Model 2 2.15 (1.23, 3.75) 2.91 (1.65, 5.15) 3.89 (1.94, 7.78) 18.79 (9.39, 37.60) 
Model 3 1.64 (0.86, 3.10) 1.58 (0.82, 3.06) 3.55 (1.76, 7.15) 16.43 (8.13, 33.18) 
Abbreviations: ASM, appendicular skeletal muscle; HDL, high density lipoprotein
The lowest tertile (tertile1) was used as reference group.
Model1: adjusted for age.
Model2: adjusted for age, smoking, drinking and physical activity.
Model3: adjusted for age, smoking, drinking, physical activity, and body fat/Ht² (ASM/Ht²).
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Table 8. Logistic regression models of ASM and body fat mass for metabolic 
abnormality in women
Women (n=747)
ASM Body fat
Tertile 2 Tertile 3 Tertile 2 Tertile 3
OR (95% CI) OR (95% CI)
High blood pressure
Model 1 1.26 (0.88, 1.81) 2.01 (1.37, 2.94) 1.77 (1.24, 2.56) 3.87 (2.65, 5.65) 
Model 2 1.33 (0.92, 1.92) 2.21 (1.49, 3.26) 1.76 (1.22, 2.53) 3.85 (2.63, 5.62) 
Model 3 1.05 (0.71, 1.55) 1.36 (0.89, 2.07) 1.55 (1.06, 2.25) 3.00 (2.00, 4.50)
Low HDL cholesterol
Model 1 1.65 (1.15, 2.38) 1.95 (1.34, 2.84) 1.86 (1.30, 2.66) 1.34 (1.22, 2.48) 
Model 2 1.66 (1.15, 2.40) 2.17 (1.47, 3.19) 1.84 (1.28, 2.64) 1.75 (1.22, 2.52)
Model 3 1.56 (1.07, 2.27) 1.90 (1.26, 2.87) 1.62 (1.12, 2.36) 1.36 (0.92, 2.01) 
High triglycerides
Model 1 1.19 (0.79, 1.80) 1.39 (0.91, 2.12) 1.82 (1.20, 2.76) 1.69 (1.11, 2.58) 
Model 2 1.17 (0.77, 1.77) 1.46 (0.95, 2.25) 1.79 (1.18, 2.73) 1.69 (1.11, 1.59) 
Model 3 1.07 (0.70, 1.64) 1.23 (0.78, 1.94) 1.69 (1.10, 2.59) 1.59 (0.94, 2.35) 
High glucose
Model 1 1.58 (1.07, 2.33) 2.07 (1.39, 3.09) 1.70 (1.15, 2.51) 2.14 (1.46, 3.13)
Model 2 1.57 (1.06, 2.32) 2.06 (1.37, 3.08) 1.74 (1.18, 2.58) 2.18 (1.48, 3.21) 
Model 3 1.39 (0.93, 2.08) 1.59 (1.03, 2.45) 1.52 (1.02, 2.27) 1.65 (1.09, 2.50) 
Metabolic syndrome
Model 1 1.68 (1.16, 2.45) 3.07 (2.08, 4.53) 3.69 (2.48, 5.49) 6.89 (4.60, 10.32)
Model 2 1.79 (1.23, 2.63) 3.54 (2.36, 5.29) 3.77 (2.52, 5.64) 7.11 (4.72, 10.72) 
Model 3 1.37 (0.91, 2.05) 1.99 (1.28, 3.09) 3.22 (2.14, 4.87) 5.14 (3.33, 7.92) 
Abbreviations: ASM, appendicular skeletal muscle; HDL, high density lipoprotein
The lowest tertile (tertile1) was used as reference group.
Model1: adjusted for age.
Model2: adjusted for age, smoking, drinking and physical activity.
Model3: adjusted for age, smoking, drinking, physical activity, and body fat (ASM).
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Table 9. Logistic regression models of ASM/Ht² and Body fat/Ht² for metabolic 
abnormality in women
Women (n=747)
ASM/Ht² Body fat/Ht²
Tertile 2 Tertile 3 Tertile 2 Tertile 3
OR (95% CI) OR (95% CI)
High blood pressure
Model 1 1.94 (1.34, 2.80)  3.24 (2.21, 4.76)  2.14 (1.49, 3.07)  3.53 (2.43, 5.14)  
Model 2 2.04 (1.41, 2.97) 3.58 (2.41, 5.31) 2.13 (1.48, 3.07) 3.46 (2.38, 5.05) 
Model 3 1.64 (1.11, 2.42) 2.39 (1.56, 3.66) 1.79 (1.23, 2.61) 2.48 (1.64, 3.73) 
Low HDL cholesterol
Model 1 1.58 (1.11, 2.27) 2.23 (1.54, 3.23) 2.41 (1.68, 3.46)  1.72 (1.20, 2.46)  
Model 2 1.66 (1.15, 2.39) 2.44 (1.66, 3.56) 2.39 (1.66, 3.45) 1.74 (1.21, 2.50) 
Model 3 1.58 (1.09, 2.30) 2.24 (1.48, 3.38) 2.04 (1.40, 2.97) 1.25 (0.84, 1.87) 
High triglycerides
Model 1 1.39 (0.92, 2.11) 1.60 (1.05, 2.43) 1.87 (1.23, 2.84)  1.83 (1.20, 2.78)  
Model 2 1.42 (0.93, 2.16) 1.66 (1.09, 2.54) 1.84 (1.21, 2.81) 1.84 (1.20, 2.81) 
Model 3 1.29 (0.84, 1.99) 1.41 (0.89, 2.23) 1.67 (1.08, 2.57) 1.51 (0.95, 2.41) 
High glucose
Model 1 1.43 (0.98, 2.09) 1.68 (1.14, 2.47) 1.89 (1.29, 2.77)  1.88 (1.28, 2.77)  
Model 2 1.43 (0.97, 2.10) 1.67 (1.13, 2.47) 1.92 (1.30, 2.82) 1.93 (1.31, 2.85) 
Model 3 1.28 (0.86, 1.90) 1.36 (0.89, 2.07) 1.73 (1.16, 2.57) 1.58 (1.04, 2.42) 
Metabolic syndrome
Model 1 1.90 (1.30, 2.76) 3.67 (2.50, 5.41) 4.38 (2.95, 6.52)  6.00 (4.02, 8.96)  
Model 2 2.05 (1.40, 3.00) 4.19 (2.81, 6.25) 4.45 (2.98, 6.64) 6.07 (4.04, 9.11) 
Model 3 1.52 (1.02, 2.28) 2.47 (1.60, 3.81) 3.71 (2.46, 5.60) 4.15 (2.69, 6.40) 
Abbreviations: ASM, appendicular skeletal muscle; HDL, high density lipoprotein
The lowest tertile (tertile1) was used as reference group.
Model1: adjusted for age.
Model2: adjusted for age, smoking, drinking and physical activity.
Model3: adjusted for age, smoking, drinking, physical activity, and body fat/Ht² (ASM/Ht²).
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6. The areas under the curves of muscle mass and fat mass in the prediction of 
metabolic abnormalities
The areas under the curves (AUC) of muscle mass and fat mass in the prediction of 
metabolic abnormalities are shown in Table 10, 11 and Figure 3, 4. In men, the AUC of fat 
mass was greater than that of muscle mass in the prediction of all of the metabolic 
abnormalities. The AUCs for body fat and body fat /Ht² for identifying High blood pressure
were 0.692 (95% CI = 0.638-0.746) and 0.689 (95% CI = 0.635-0.743); low HDL cholesterol 
were 0.640 (95% CI = 0.582-0.697) and 0.627 (95% CI = 0.569-0.684); high triglycerides 
were 0.616 (95% CI = 0.556-0.677) and 0.607 (95% CI = 0.547-0.667); high glucose were 
0.650 (95% CI = 0.595-0.705) and 0.645 (95% CI = 0.589-0.701); metabolic syndrome were 
0.813 (95% CI = 0.768-0.857) and 0.799 (95% CI = 0.754-0.845), respectively (Table 10 and 
Figure 3). In women, the AUC of fat mass was greater than that of muscle mass in the 
prediction of high blood pressure, high triglycerides and metabolic syndrome. The AUCs for 
body fat and body fat /Ht² for identifying high blood pressure were 0.660 (95% CI = 0.621-
0.699) and 0.659 (95% CI = 0.620-0.698); high triglycerides were 0.573 (95% CI = 0.527-
0.618) and 0.570 (95% CI = 0.524-0.616); metabolic syndrome were 0.717 (95% CI = 0.680-
0.753) and 0.700 (95% CI = 0.663-0.737), respectively. The AUC of fat mass and muscle 
mass were showed similar in the prediction of low HDL cholesterol and high glucose. The 
AUCs for ASM/Ht² and body fat for identifying low HDL cholesterol were 0.581 (95% CI = 
0.524-0.607) and 0.572 (95% CI = 0.530-0.614), respectively. The AUCs for ASM and body 
fat for identifying high glucose were 0.584 (95% CI = 0.541-0.672) and 0.591 (95% CI =
0.548-0.633), respectively (Table 11 and Figure 4).
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Table 10. Comparison of areas under ROC curve for different muscle mass and fat mass by metabolic abnormalities in men
Men (n=381)
Areas under ROC curve for 95% CI
High blood pressure Low HDL cholesterol High triglycerides High glucose Metabolic syndrome
ASM 0.536(0.477-0.595) 0.587(0.525-0.649) 0.570(0.506-0.634) 0.545(0.487-0.603) 0.611 (0.553-0.669)
Body fat 0.692(0.638-0.746) 0.640(0.582-0.697) 0.616(0.556-0.677) 0.650(0.595-0.705) 0.813 (0.768-0.857)
ASM/Ht² 0.554(0.495-0.614) 0.587(0.526-0.648) 0.562(0.499-0.625) 0.549(0.491-0.607) 0.628 (0.571-0.685)
Body fat/Ht² 0.689(0.635-0.743) 0.627(0.569-0.684) 0.607(0.547-0.667) 0.645(0.589-0.701) 0.799 (0.754-0.845)
Abbreviations: ASM, appendicular skeletal muscle; HDL, high density lipoprotein
Table 11. Comparison of areas under ROC curve for different muscle mass and fat mass by metabolic abnormalities in women
Women (n=747)
Areas under ROC curve for 95% CI
High blood pressure Low HDL cholesterol High triglycerides High glucose Metabolic syndrome
ASM 0.568(0.527-0.609) 0.559(0.518-0.601) 0.538(0.492-0.585) 0.584(0.541-0.672) 0.614 (0.574-0.655)
Body fat 0.660(0.621-0.699) 0.572(0.530-0.614) 0.573(0.527-0.618) 0.591(0.548-0.633) 0.717 (0.680-0.753)
ASM/Ht² 0.605(0.564-0.645) 0.581(0.540-0.622) 0.558(0.512-0.605) 0.560(0.517-0.603) 0.633 (0.594-0.673)
Body fat/Ht² 0.659(0.620-0.698) 0.565(0.524-0.607) 0.570(0.524-0.616) 0.571(0.528-0.614) 0.700 (0.663-0.737)
Abbreviations: ASM, appendicular skeletal muscle; HDL, high density lipoprotein
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Figure.3 Receiver operating characteristic curve of muscle mass and fat mass and metabolic abnormalities in men
High blood pressure High glucose
Low HDL cholesterol High triglycerides Metabolic syndrome
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Metabolic syndrome
High glucose
Low HDL cholesterol
High blood pressure
High triglycerides
Figure.4 Receiver operating characteristic curve of muscle mass and fat mass and metabolic abnormalities in women
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IV. DISCUSSION
1. Summary of finding
The present study investigated that fat mass and muscle mass were associated with the 
metabolic syndrome along with its components in Korean older adults. We observed that 
higher fat mass was associated with increased risk of metabolic syndrome along with its 
components in both men and women. Furthermore, higher muscle mass was associated with 
increased risk of high blood pressure, low HDL cholesterol, high glucose and metabolic 
syndrome after adjustment for body fat and potential confounders only in women. Muscle 
mass is strongly correlated with fat mass in women than in men.
2. Comparison with previous studies
In the elderly population, body composition such as fat mass and muscle mass, gradually 
changes with age even if the body weight remains unchanged (Gallagher et al. 2000; Kim et 
al. 2014). Previous studies have proven that fat mass is associated with inflammatory markers 
and metabolic abnormalities (Bosy-Westphal et al. 2006a; Forouhi, Sattar and McKeigue 
2001). Consistent with those studies, our study showed that fat mass was related to metabolic 
abnormalities, independent of muscle mass and other potential confounders.
Meanwhile, previous studies have reported that low muscle mass reduces the intensity and 
endurance of physical activity (Wannamethee and Atkins 2015). These changes may increase 
of obesity and obesity-relates metabolic abnormalities in older people (Ishii et al. 2014; 
Karakelides and Nair 2005) and muscular strength was inversely associated with incident 
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metabolic syndrome (Jurca et al. 2005). Furthermore, both obesity and sarcopenia are 
associated with metabolic disorders and are important causes of disability, morbidity and 
mortality (Stephen and Janssen 2009; Wannamethee and Atkins 2015). However, our study 
showed that the positive associations between muscle mass and high blood pressure, low 
HDL cholesterol, high glucose and metabolic syndrome were observed only in women. These 
results show that women with high muscle mass have an especially greater risk of metabolic 
abnormalities than those with lower muscle mass, but this is not consistent with previous 
studies.
3. Possible mechanism
One of the possible underlying factors is validation of a BIA equation to predict muscle 
mass and fat mass. The BIA is simple, noninvasive, relatively inexpensive, easy-to-use 
method of estimating body composition. Numerous studies have developed equations for 
estimating lean body mass from BIA measurements (Bosaeus et al. 2014; Rangel Peniche, 
Raya Giorguli and Aleman-Mateo 2015). However, to ensure that reliable BIA measurements 
are obtained, several factors such as hydration status, food intake, and exercise must be 
controlled (Thibault, Genton and Pichard 2012). 
Another possible underlying factor is the age-specific effects of metabolic syndrome. In 
middle aged populations, metabolic syndrome has been proven a relevant determinant of
association with several outcomes, including cardiovascular and cerebrovascular morbidity 
and mortality (Thomas et al. 2007). In contrast, several recent studies have suggested that the 
different effects of metabolic syndrome in older population. Higher blood pressure levels 
have been associated with better cognitive functioning and faster walking speed in elderly 
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adults (Odden et al. 2012; Zuccala et al. 2005). Faster walking speed, also often termed gait 
speed, has been shown to reflect muscle mass (Auyeung et al. 2014; Patil et al. 2013).
Consistent with those studies, our finding suggest that higher ASM/Ht2 was associated with 
an increased risk of high blood pressure. In a more general sense, older age might represent a 
condition of frailty, which is associated with the epidemiological phenomenon of “reverse 
epidemiology” (Chien et al. 2012; Guder et al. 2015). In this perspective, our study supported 
that muscle mass is an independent risk factor for metabolic abnormalities. However, the 
aforementioned studies included hospitalized patients or, very old subjects or Western 
population, thus these findings are limited to apply to healthy older people.
Additionally, our findings for muscle mass may be explained by assuming that the higher 
muscle mass group includes subjects with both obesity and high fat mass. A study by 
Kimyagarov et al (2010), when body composition was analyzed according to the three BMI 
groups, subjects with normal BMI show a significantly increased absolute body fat and body 
fat/Ht2 , but not muscle mass from those in the low and high BMI groups (Kimyagarov et al. 
2010). However, our study shows that increases in muscle mass have been shown to be 
related to increased body fat and grip strength. On the other hand, increases in body fat have 
been shown to be related to increased muscle mass but not grip strength. These finding are 
suggested that fat mass and muscle mass are not biologically independent. In our study, 
among the highest tertile of muscle mass they simultaneously included high body fat and high 
muscle mass groups, and low body fat and high muscle mass group, thus adjustment for body 
fat as a covariate might be inadequate.
In addition, we used ROC analysis to address the issue of discriminative performance. 
Body fat seems to be a better predictor of metabolic abnormalities in men, while muscle and 
fat mass indices are similar prediction in women. These result demonstrated that the pattern 
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and magnitude of body composition changes varied for the different indices of muscle and fat 
mass, was not similar for men and women (Strugnell et al. 2014).
4. Limitations
Our study has several limitations. First, muscle mass and fat mass does not directly assess 
the) deposition of body composition such as DXA. Thus, we could not address the 
relationship between direct measures and metabolic abnormalities. Second, since the subjects 
were community-dwelling older adults, our findings may not be able to be generalized to 
older Korean adults from other racial/ethnic groups. Finally, our study was a cross-sectional 
analysis which did not establish a causative relationship between muscle mass and fat mass 
with metabolic abnormalities.
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V. CONCLUSIONS
The findings of the present study indicated that higher muscle mass and fat mass further 
increases the risks of metabolic abnormalities, such as high blood pressure, low HDL 
cholesterol, high glucose and metabolic syndrome even adjustment of age and body 
composition in older adult Korean women. This study adds to the growing knowledge on the 
better predictor of metabolic abnormalities is fat mass than muscle mass in men, and muscle 
mass is also predicted metabolic abnormalities in women. Further longitudinal studies are 
required to clarify the mechanism by which muscle mass is related to the development of 
metabolic abnormality among older adults.
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ABSTRACT (KOREAN)
‘노년 인구의 근육량, 체지방량과 대사위험요인과의 관련성’
지도교수 김현창
연세대학교 대학원 보건학과
박지혜
연구 배경 및 목적: 
최근 노년 인구에서 sarcopenia는 대사이상과 관련성이 있다고 보고되고 있다. 
그러나 sarcopenia의 기준은 통일되어 있지 않고 어떤 기준을 따라야 하는지에 대한
논의가 계속되고 있다. 이에 본 연구에서는 sarcopenia를 정의하기 이전에 근육의
절대량과 대사위험요인 간의 관련성을 분석하고자 하였다. 
연구 방법:
본 연구는 지역사회기반 전향적 코호트인 Korean Urban Rural Elderly (KURE) 
study의 일부로, 2014년에 연구 참여에 동의한 65세 이상의 성인을 대상으로
시행되었다. 대상자 중 917명은 체성분 검사와 혈액 검사 모두를 2014년에
시행하였으나 368명은 체성분 검사는 2014년에, 혈액 검사는 2012년에 시행하였다.
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체성분은 인바디 720(바이오스페이스)를 통해 측정하였고, 대사위험요인 지표들은 공복
혈액에서 측정되었다. 근육량, 체지방량과 대사위험요인과의 관련성을 보기 위해
상관분석, 일반선형 및 다변량회귀 분석을 하였고 혼란변수로는 연령, 흡연 및 음주
습관, 신체활동 수준과 각각 근육량과 체지방량을 보정하였다.
연구 결과:
근육량을 3구간으로 나누어 보았을 때 남녀 모두에서 근육량이 증가할수록
체지방량도 통계적으로 유의하게 증가하였다. 체지방량과 모든 대사위험요인은 연령, 
흡연 및 음주 습관, 신체활동 수준과 근육량을 보정하였을 때 남자와 여자 모두에서
통계적으로 유의한 관련성을 보였으나 근육량과 대사위험요인은 연령, 흡연 및 음주
습관, 신체활동 수준과 체지방량을 보정하였을 때 여자에서 근육량이 많을 수록 혈압이
높을 오즈비가 2.46 (95% CI 1.61-3.75), HDL이 낮을 오즈비가 2.25 (95% CI 1.49-
3.38), 혈당이 높을 오즈비가 1.61 (95% CI 1.05-2.48)로 독립적인 관련성을 보였고, 
남자에서는 HDL이 낮을 오즈비가 1.88 (95% CI 1.01-3.49)으로 나머지 위험요인과는
통계적으로 유의한 관련성을 보이지 않았다.
고찰: 
본 연구에서는 노년 인구에서 체지방의 증가뿐 아니라 근육량의 증가도
대사위험요인과 높은 상관성을 보였고 성에 따라 결과에 차이가 있었다. 특히
남자에서는 근육량과 HDL이, 여자에서는 혈압, HDL, 혈당, 대사증후군과 독립적인
관련성이 있었다. 근육량, 체지방량과 대사위험요인과의 인과적인 관계에 대한 평가를
위해서는 추후 전향적인 연구가 뒷받침 되어야 할 것이다.
핵심단어: 근육량, 체지방량, 대사위험요인, 노년 인구
